Effect of CPAP treatment on endothelial function, inflammatory markers, blood pressure and glucose control in patients with OSAS with emphasis on gender differences

A. Panoutsopoulos, A. Kallianos, A. Pappas, L. Velentza, C. Mermigkis, K. Kostopoulos, V. Kouranos, A. Rapti, E. Koufogiorga, A. Mitrakou, C. Kostopoulos, N. Zakopoulos, I. Nikolopoulos (Athens, Greece)

Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea
Session: Cardiometabolic and neurocognitive changes in obstructive sleep apnoea
Session type: Thematic Poster Session
Number: 2227
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Panoutsopoulos, A. Kallianos, A. Pappas, L. Velentza, C. Mermigkis, K. Kostopoulos, V. Kouranos, A. Rapti, E. Koufogiorga, A. Mitrakou, C. Kostopoulos, N. Zakopoulos, I. Nikolopoulos (Athens, Greece). Effect of CPAP treatment on endothelial function, inflammatory markers, blood pressure and glucose control in patients with OSAS with emphasis on gender differences. Eur Respir J 2011; 38: Suppl. 55, 2227

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of continuous positive airway pressure on lipid profile in patients with severe OSAS
Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Year: 2018

Effect of CPAP treatment on endothelial function, inflammatory markers, blood pressure and glucose control in male and female patients with OSAS
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014

Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment
Source: Eur Respir J 2006; 27: 756-760
Year: 2006



Glucose metabolism markers in non-diabetic OSAS patients. Effect of compliance to CPAP treatment
Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea
Year: 2008

Effect of continuous positive airway pressure on blood pressure and metabolic profile in women with sleep apnoea
Source: Eur Respir J, 50 (2) 1700257; 10.1183/13993003.00257-2017
Year: 2017



Positive effect of CPAP therapy in OSA patients on A-FABP, CRP and triacylglycerols levels and diastolic blood pressure
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012

3 month continuous positive airway pressure (CPAP) therapy decreases serum lipids, but not homocysteine and leptin concentration in patients with OSAS
Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea
Year: 2009


Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome
Source: Annual Congress 2005 - Metabolic control in OSA
Year: 2005


The influence of 3-weeks‘ therapy of continous positive airway pressure (CPAP) on serum leptin and homocysteine concentration in patients with obstructive sleep apnea (OSA)
Source: Annual Congress 2005 - Metabolic control in OSA
Year: 2005


Influence of continuous positive airway pressure therapy on endothelial function and blood pressure in patients with arterial hypertension and obstructive sleep apnoea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 814s
Year: 2006

OSAS as a link between diseases of different systems
Source: Annual Congress 2007 - Clinical year in review
Year: 2007


Resting electrocardiographic (EKG) changes, the cardiovascular risk factors and the effect of CPAP (continuous positive airways pressure) therapy on high blood pressure evolution in patients with sleep apnoea syndrome
Source: Eur Respir J 2005; 26: Suppl. 49, 564s
Year: 2005

Effects of continuous positive airway pressure therapy in patients with severe obstructive sleep apnea and endothelial dysfunction on 24-hour blood pressure profile
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015


Positive effect of CPAP treatment on the control of difficult-to-treat hypertension
Source: Eur Respir J 2007; 29: 951-957
Year: 2007



The effect of treatment for sleep apnoea on determinants of blood pressure control
Source: Eur Respir J, 50 (5) 1701261; 10.1183/13993003.01261-2017
Year: 2017



Differential blood pressure response to continuous positive airway pressure treatment according to the circadian pattern in hypertensive patients with obstructive sleep apnoea
Source: Eur Respir J, 54 (1) 1900098; 10.1183/13993003.00098-2019
Year: 2019



Impact of long-term oxygen therapy on morphological changes of red blood cells and NT-proBNP level in COPD patients.
Source: International Congress 2017 – COPD biomarkers
Year: 2017


Effect of continuous positive airway pressure on 24 h ambulatory blood pressure in hypertensive patients with OSA
Source: Eur Respir J 2007; 30: Suppl. 51, 333s
Year: 2007

Effect and significance of continuous positive airway pressure treatment on vascular endothelial function in patients with obstructive sleep apnoea syndrome
Source: Annual Congress 2003 - Systematic inflammation and metabolic disorders in sleep related breathing disorders
Year: 2003


Effect of continuous positive airway pressure (CPAP) treatment on proangiogenic factors of angiogenesis in obstructive sleep apnea (OSA) patients
Source: Eur Respir J 2005; 26: Suppl. 49, 39s
Year: 2005